| Revision as of 21:03, 24 May 2006 edit80.221.44.147 (talk)No edit summary← Previous edit | Revision as of 19:30, 27 May 2006 edit undoEpimetreus (talk | contribs)200 editsm tiny typo fixNext edit → | ||
| Line 8: | Line 8: | ||
| Acquisitions have included ] for slide-based microarrays and scanners and Neomorphic for ]. In ] ] was spun out to focus on wafer-scale genomics for massive data creation and collection required for characterizing population variance of genomic markers and expression for the drug discovery process. | Acquisitions have included ] for slide-based microarrays and scanners and Neomorphic for ]. In ] ] was spun out to focus on wafer-scale genomics for massive data creation and collection required for characterizing population variance of genomic markers and expression for the drug discovery process. | ||
| Early on Affymetrix formed a partnership with ] Chemical Analysis, now ] Life Sciences. That relationship soured when Affymetrix acquired |
Early on Affymetrix formed a partnership with ] Chemical Analysis, now ] Life Sciences. That relationship soured when Affymetrix acquired its own world-class instrument development team and now the two companies are competitors. Today, using the instrument development and manfacturing teams based in Bedford, MA that evolved from the acqusition of ] Affymetrix designs and manufactures its own genomics instrumentation systems as well as performing advanced research in creating new technologies to be used in future genomic instrumentation systems. | ||
| ==External links== | ==External links== | ||
Revision as of 19:30, 27 May 2006
Affymetrix Nasdaq: AFFX was founded by Stephen P.A. Fodor, Ph.D. and others in the late 1980s with the revolutionary idea to use semiconductor manufacturing techniques to create GeneChips (an Affymetrix trademark) or generically DNA microarrays. The company has an impressive patent portfolio in this area.
Affymetrix was originally a division of Affymax, but was spun out in 1992. It launched its first product, an HIV genotyping GeneChip, in 1994. Affymetrix went public in 1996.
Acquisitions have included Genetic MicroSystems for slide-based microarrays and scanners and Neomorphic for bioinformatics. In 2000 Perlegen Sciences was spun out to focus on wafer-scale genomics for massive data creation and collection required for characterizing population variance of genomic markers and expression for the drug discovery process.
Early on Affymetrix formed a partnership with Hewlett-Packard Chemical Analysis, now Agilent Life Sciences. That relationship soured when Affymetrix acquired its own world-class instrument development team and now the two companies are competitors. Today, using the instrument development and manfacturing teams based in Bedford, MA that evolved from the acqusition of Genetic MicroSystems Affymetrix designs and manufactures its own genomics instrumentation systems as well as performing advanced research in creating new technologies to be used in future genomic instrumentation systems.